Aarti Pharmalabs Limited (NSE:AARTIPHARM)

Aarti Pharmalabs Statistics

Total Valuation

NSE:AARTIPHARM has a market cap or net worth of INR 64.16 billion. The enterprise value is 70.35 billion.

Market Cap	64.16B
Enterprise Value	70.35B

Important Dates

The last earnings date was Sunday, November 9, 2025.

Earnings Date	Nov 9, 2025
Ex-Dividend Date	Sep 15, 2025

Share Statistics

NSE:AARTIPHARM has 90.65 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	90.65M
Shares Outstanding	90.65M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	29.42%
Owned by Institutions (%)	20.32%
Float	48.09M

Valuation Ratios

The trailing PE ratio is 26.77.

PE Ratio	26.77
Forward PE	n/a
PS Ratio	3.37
PB Ratio	3.14
P/TBV Ratio	3.32
P/FCF Ratio	n/a
P/OCF Ratio	20.08
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.12, with an EV/FCF ratio of -56.50.

EV / Earnings	29.34
EV / Sales	3.69
EV / EBITDA	16.12
EV / EBIT	20.19
EV / FCF	-56.50

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.33.

Current Ratio	1.64
Quick Ratio	0.67
Debt / Equity	0.33
Debt / EBITDA	1.54
Debt / FCF	-5.42
Interest Coverage	10.31

Financial Efficiency

Return on equity (ROE) is 12.29% and return on invested capital (ROIC) is 8.83%.

Return on Equity (ROE)	12.29%
Return on Assets (ROA)	7.26%
Return on Invested Capital (ROIC)	8.83%
Return on Capital Employed (ROCE)	14.29%
Revenue Per Employee	8.82M
Profits Per Employee	1.11M
Employee Count	2,162
Asset Turnover	0.63
Inventory Turnover	1.49

Taxes

In the past 12 months, NSE:AARTIPHARM has paid 796.39 million in taxes.

Income Tax	796.39M
Effective Tax Rate	24.93%

Stock Price Statistics

The stock price has increased by +9.94% in the last 52 weeks. The beta is -0.36, so NSE:AARTIPHARM's price volatility has been lower than the market average.

Beta (5Y)	-0.36
52-Week Price Change	+9.94%
50-Day Moving Average	792.13
200-Day Moving Average	819.77
Relative Strength Index (RSI)	43.76
Average Volume (20 Days)	311,515

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:AARTIPHARM had revenue of INR 19.06 billion and earned 2.40 billion in profits. Earnings per share was 26.44.

Revenue	19.06B
Gross Profit	9.08B
Operating Income	3.51B
Pretax Income	3.19B
Net Income	2.40B
EBITDA	4.34B
EBIT	3.51B
Earnings Per Share (EPS)	26.44

Balance Sheet

The company has 555.56 million in cash and 6.75 billion in debt, giving a net cash position of -6.19 billion or -68.30 per share.

Cash & Cash Equivalents	555.56M
Total Debt	6.75B
Net Cash	-6.19B
Net Cash Per Share	-68.30
Equity (Book Value)	20.46B
Book Value Per Share	225.70
Working Capital	5.16B

Cash Flow

In the last 12 months, operating cash flow was 3.20 billion and capital expenditures -4.44 billion, giving a free cash flow of -1.25 billion.

Operating Cash Flow	3.20B
Capital Expenditures	-4.44B
Free Cash Flow	-1.25B
FCF Per Share	-13.74

Margins

Gross margin is 47.64%, with operating and profit margins of 18.40% and 12.58%.

Gross Margin	47.64%
Operating Margin	18.40%
Pretax Margin	16.76%
Profit Margin	12.58%
EBITDA Margin	22.75%
EBIT Margin	18.40%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.71%.

Dividend Per Share	5.00
Dividend Yield	0.71%
Dividend Growth (YoY)	66.67%
Years of Dividend Growth	2
Payout Ratio	18.38%
Buyback Yield	-0.06%
Shareholder Yield	0.66%
Earnings Yield	3.74%
FCF Yield	-1.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5